Text Message Reminders for the Second Dose of Influenza Vaccine for Children: An RCT.


Journal

Pediatrics
ISSN: 1098-4275
Titre abrégé: Pediatrics
Pays: United States
ID NLM: 0376422

Informations de publication

Date de publication:
01 09 2022
Historique:
accepted: 17 05 2022
pubmed: 15 8 2022
medline: 9 9 2022
entrez: 14 8 2022
Statut: ppublish

Résumé

Among children requiring 2 influenza doses in a given season, second dose receipt nearly halves the odds of influenza. Nationally, many children do not receive both needed doses. This study sought to compare the effectiveness of text message reminders with embedded interactive educational information versus usual care on receipt and timeliness of the second dose of influenza vaccine. This trial took place over the 2017 to 2018 and 2018 to 2019 influenza seasons among 50 pediatric primary care offices across 24 states primarily from the American Academy of Pediatrics' Pediatric Research in Office Settings practice-based research network. Caregiver-child dyads of children 6 months to 8 years in need of a second influenza vaccination that season were individually randomized 1:1 into intervention versus usual care, stratified by age and language within each practice. Intervention caregivers received automated, personalized text messages, including educational information. Second dose receipt by April 30 (season end) and by day 42 (2 weeks after second dose due date) were assessed using Mantel Haenszel methods by practice and language. Analyses were intention to treat. Among 2086 dyads enrolled, most children were 6 to 23 months and half publicly insured. Intervention children were more likely to receive a second dose by season end (83.8% versus 80.9%; adjusted risk difference (ARD) 3.8%; 95% confidence interval [0.1 to 7.5]) and day 42 (62.4% versus 55.7%; ARD 8.3% [3.6 to 13.0]). In this large-scale trial of primary care pediatric practices across the United States, text message reminders were effective in promoting increased and timelier second dose influenza vaccine receipt.

Sections du résumé

BACKGROUND AND OBJECTIVES
Among children requiring 2 influenza doses in a given season, second dose receipt nearly halves the odds of influenza. Nationally, many children do not receive both needed doses. This study sought to compare the effectiveness of text message reminders with embedded interactive educational information versus usual care on receipt and timeliness of the second dose of influenza vaccine.
METHODS
This trial took place over the 2017 to 2018 and 2018 to 2019 influenza seasons among 50 pediatric primary care offices across 24 states primarily from the American Academy of Pediatrics' Pediatric Research in Office Settings practice-based research network. Caregiver-child dyads of children 6 months to 8 years in need of a second influenza vaccination that season were individually randomized 1:1 into intervention versus usual care, stratified by age and language within each practice. Intervention caregivers received automated, personalized text messages, including educational information. Second dose receipt by April 30 (season end) and by day 42 (2 weeks after second dose due date) were assessed using Mantel Haenszel methods by practice and language. Analyses were intention to treat.
RESULTS
Among 2086 dyads enrolled, most children were 6 to 23 months and half publicly insured. Intervention children were more likely to receive a second dose by season end (83.8% versus 80.9%; adjusted risk difference (ARD) 3.8%; 95% confidence interval [0.1 to 7.5]) and day 42 (62.4% versus 55.7%; ARD 8.3% [3.6 to 13.0]).
CONCLUSIONS
In this large-scale trial of primary care pediatric practices across the United States, text message reminders were effective in promoting increased and timelier second dose influenza vaccine receipt.

Identifiants

pubmed: 35965283
pii: 188765
doi: 10.1542/peds.2022-056967
pmc: PMC9592065
mid: NIHMS1840138
pii:
doi:

Substances chimiques

Influenza Vaccines 0

Banques de données

ClinicalTrials.gov
['NCT03287830']

Types de publication

Journal Article Randomized Controlled Trial Research Support, U.S. Gov't, P.H.S. Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD086045
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Prev Med. 2013 Mar;56(3-4):165-70
pubmed: 23219757
Am J Public Health. 2013 Jul;103(7):e50-8
pubmed: 23678935
JAMA. 2012 Apr 25;307(16):1702-8
pubmed: 22535855
Hum Vaccin Immunother. 2020 May 3;16(5):1070-1077
pubmed: 32017643
MMWR Morb Mortal Wkly Rep. 2010 Aug 27;59(33):1057-62
pubmed: 20798667
Trends Microbiol. 2016 Feb;24(2):123-133
pubmed: 26612500
N Engl J Med. 2000 Jan 27;342(4):225-31
pubmed: 10648763
Am J Public Health. 2009 Dec;99(12):2176-8
pubmed: 19833982
Pediatrics. 2016 Mar;137(3):e20153280
pubmed: 26908692
J Community Health. 2015 Apr;40(2):227-34
pubmed: 25082482
Epidemiology. 2010 Jan;21(1):13-5
pubmed: 20010207
Vaccine. 2007 Jun 28;25(27):5086-96
pubmed: 17544181
Vaccine. 2018 Jun 22;36(27):3960-3966
pubmed: 29801998
Pediatrics. 2015 Nov;136(5):e1220-7
pubmed: 26438703
Am J Prev Med. 2016 Mar;50(3):398-401
pubmed: 26547538
Clin Infect Dis. 2020 Jun 10;70(12):2496-2502
pubmed: 31344229
MMWR Recomm Rep. 2020 Aug 21;69(8):1-24
pubmed: 32820746
Pediatrics. 2015 Jan;135(1):e83-91
pubmed: 25548329
MMWR Morb Mortal Wkly Rep. 2018 Oct 26;67(42):1178-1185
pubmed: 30359347
Vaccine. 2012 Aug 3;30(36):5305-9
pubmed: 22750044
J Infect Dis. 2002 Jan 15;185(2):147-52
pubmed: 11807687
Am J Prev Med. 2015 Apr;48(4):392-401
pubmed: 25812465
Vaccine. 2013 Jun 28;31(31):3116-20
pubmed: 23684827
Clin Infect Dis. 2012 May;54(10):1427-36
pubmed: 22495079
Am J Prev Med. 2017 Apr;52(4):e103-e113
pubmed: 28012814
Clin Infect Dis. 2019 Nov 13;69(11):1845-1853
pubmed: 30715278
Stat Methods Med Res. 2010 Feb;19(1):71-99
pubmed: 19654170
JAMA. 2004 Sep 15;292(11):1333-40
pubmed: 15367555
Pediatrics. 2015 Jan;135(1):e66-74
pubmed: 25489015
Biometrics. 2000 Mar;56(1):304-8
pubmed: 10783812
Pediatrics. 2017 May;139(5):
pubmed: 28557757
JAMA Pediatr. 2020 Jul 1;174(7):705-713
pubmed: 32364599
Pediatrics. 2019 Oct;144(4):
pubmed: 31477606

Auteurs

Melissa S Stockwell (MS)

Division of Child and Adolescent Health, Department of Pediatrics, Columbia University, New York, New York.
Department of Population and Family Health, Mailman School of Public Health, Columbia University, New York, New York.
Contributed equally as co-senior authors.

Laura P Shone (LP)

Primary Care Research, American Academy of Pediatrics, Itasca, Illinois.

Ekaterina Nekrasova (E)

Department of Pediatrics, Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Chelsea Wynn (C)

Division of Child and Adolescent Health, Department of Pediatrics, Columbia University, New York, New York.

Alessandra Torres (A)

Primary Care Research, American Academy of Pediatrics, Itasca, Illinois.

Miranda Griffith (M)

Primary Care Research, American Academy of Pediatrics, Itasca, Illinois.

Justine Shults (J)

Department of Biostatistics, Epidemiology & Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Rebecca Unger (R)

Northwestern Children's Practice, Chicago, Illinois.

Leigh Ann Ware (LA)

Building Blocks Pediatrics, Pleasanton, Texas.

Chelsea Kolff (C)

Division of Child and Adolescent Health, Department of Pediatrics, Columbia University, New York, New York.
Department of Population and Family Health, Mailman School of Public Health, Columbia University, New York, New York.

Donna Harris (D)

Primary Care Research, American Academy of Pediatrics, Itasca, Illinois.

Lindsay Berrigan (L)

Department of Pediatrics, Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Heather Montague (H)

Primary Care Research, American Academy of Pediatrics, Itasca, Illinois.
American Academy of Dental Sleep Medicine, Lisle, Illinois.

A Russell Localio (AR)

Department of Biostatistics, Epidemiology & Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Alexander G Fiks (AG)

Department of Pediatrics, Center for Pediatric Clinical Effectiveness, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Contributed equally as co-senior authors.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH